Diabetic nephropathy (DN) is one of the most serious long-term consequences of type 2 diabetes mellitus (T2DM) because it causes end-stage renal disease (ESRD). We established this study to evaluate the urinary GPC5 level in T2DM as an early marker for DN.
(2023). Study and Clinical Significance of Urinary Levels of Glypican 5 in Diabetic Patients. Egyptian Society of Diabetes and Lipidology Journal, 3(2), -. doi: 10.21608/esdlj.2023.456213
MLA
. "Study and Clinical Significance of Urinary Levels of Glypican 5 in Diabetic Patients", Egyptian Society of Diabetes and Lipidology Journal, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456213
HARVARD
(2023). 'Study and Clinical Significance of Urinary Levels of Glypican 5 in Diabetic Patients', Egyptian Society of Diabetes and Lipidology Journal, 3(2), pp. -. doi: 10.21608/esdlj.2023.456213
VANCOUVER
Study and Clinical Significance of Urinary Levels of Glypican 5 in Diabetic Patients. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456213
)
